<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JAP</journal-id>
<journal-id journal-id-type="hwp">spjap</journal-id>
<journal-title>Journal of the American Psychiatric Nurses Association</journal-title>
<issn pub-type="ppub">1078-3903</issn>
<issn pub-type="epub">1532-5725</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1078390313495563</article-id>
<article-id pub-id-type="publisher-id">10.1177_1078390313495563</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Special Section on Competency Based Training Related to Suicide</subject>
<subj-group subj-group-type="heading">
<subject>Evidence-Based Practice Column</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Evidence-Based Practice</article-title>
<subtitle>A Model for Clinical Application</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Rice</surname><given-names>Michael J.</given-names></name>
<xref ref-type="aff" rid="aff1-1078390313495563">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1078390313495563"><label>1</label>Michael J. Rice, PhD, APRN, BC, FAAN, University of Colorado, Aurora, CO, USA</aff>
<author-notes>
<corresp id="corresp1-1078390313495563">Michael J. Rice, University of Colorado, College of Nursing, Anschutz Medical Center, Campus Box C-288-03, Bldg P28Center, 13120 E. 19th Ave, Aurora, CO 80054, USA. Email: <email>mjrice@unmc.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2013</year>
</pub-date>
<volume>19</volume>
<issue>4</issue>
<fpage>217</fpage>
<lpage>221</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">American Psychiatric Nurses Association</copyright-holder>
</permissions>
<abstract>
<p>Health care reform authorized by the Affordable Care Act is based on the belief that evidence-based practice (EBP) generates cost savings due to the delivery of more effective care. Published meta-analyses and systematic reviews provide clear, unbiased evidence on the effectiveness of specific interventions. Yet translating the interventions into the practice setting requires additional clinical skills and judgments extending beyond the scientific assessment of the EBP literature. Effective use of EBP interventions requires clinicians effectively answering an additional set of questions specific to the case and clinical context. These questions focus on correctly identifying the problem and increased level of specificity for any given situation. Using a clinical application of the PICO model, the clinician and the patient should be able to achieve a higher level of clinical outcomes.</p>
</abstract>
<kwd-group>
<kwd>evidence based</kwd>
<kwd>psychiatric care</kwd>
<kwd>PICO</kwd>
<kwd>clinical application</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>July/August 2013</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Health care reform authorized by the Affordable Care Act (ACA) is based on the belief that implementation of evidence-based practices (EBPs) generates cost savings due to the delivery of more effective care. The ACA mandate reinforces use of EBP by directly connecting reimbursement to the use of EBPs (<xref ref-type="bibr" rid="bibr5-1078390313495563">Department of Health and Human Services, 2011</xref>). While the ACA legislation increases organizational and professional interest, a gap remains between the EBP research model and direct clinical application. Applying EBP interventions into clinical practice requires additional skills not addressed in the traditional EBP research literature.</p>
<sec id="section1-1078390313495563">
<title>Clinical Application Model</title>
<p>The EBP literature acknowledges that clinical application relies heavily on an individual clinician’s skills (<xref ref-type="bibr" rid="bibr20-1078390313495563">Melnyk &amp; Fineout-Overholt, 2005</xref>, <xref ref-type="bibr" rid="bibr21-1078390313495563">2006</xref>) and collaboration with the patient (<xref ref-type="bibr" rid="bibr17-1078390313495563">McAlister, Straus, Guyatt, &amp; Haynes, 2000</xref>; <xref ref-type="bibr" rid="bibr24-1078390313495563">Rice, 2008</xref>). However, application in clinical settings is more complex because of a range of additional variables, often controlled in the study design, which affect the patient status and outcomes. What is missing in the EBP literature is a clear application model for patients who may or may not be similar to those with whom the EBP intervention was tested.</p>
<p>A viable model for clinical application of the EBP interventions begins using the same template used to search for the best EBPs. The model consists of the familiar elements of the population of interest (P), interventions (I), a comparison group or intervention (C), and an outcome (O), commonly referred to as a PICO question (<xref ref-type="bibr" rid="bibr7-1078390313495563">Fineout-Overholt &amp; Johnston, 2005</xref>, <xref ref-type="bibr" rid="bibr8-1078390313495563">2007</xref>; <xref ref-type="bibr" rid="bibr19-1078390313495563">Melnyk, 2003</xref>; <xref ref-type="bibr" rid="bibr24-1078390313495563">Rice, 2008</xref>). While there is some literature on the use of the PICO model in refining the search question based on the clinical need (<xref ref-type="bibr" rid="bibr26-1078390313495563">Rice, 2010</xref>), there are no instructions on applying the model to clinical practice. When used as a model for clinical application of EBP, the PICO questions are refocused on precise elements of the clinical situation: patient specificity (P), intervention effectiveness (I), comparative treatments (C), and outcomes (O).</p>
</sec>
<sec id="section2-1078390313495563">
<title>Patient Specificity</title>
<p>Patient specificity in EBP implies that the treatment intervention is specific for the patient population or disease. Prior to implementing an EBP intervention, clinicians must ask two questions about the clinical population (P): (a) Is the diagnosis or condition as presented in the clinical encounter the same as identified in the literature for the intervention? (b) Does the literature on the intervention report that characteristics of the population tested are similar to the clinical population where the intervention will be applied? (<xref ref-type="table" rid="table1-1078390313495563">Table 1</xref>).</p>
<table-wrap id="table1-1078390313495563" position="float">
<label>Table 1.</label>
<caption>
<p>PICO Questions for Clinical Application.</p>
</caption>
<graphic alternate-form-of="table1-1078390313495563" xlink:href="10.1177_1078390313495563-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">PICO model</th>
<th align="center">Clinical application</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="2">Patient/Condition Specificity</td>
<td>1. Is the diagnosis or condition as presented in the clinical encounter the same as identified in the literature for the intervention?</td>
</tr>
<tr>
<td>2. Does the literature on the intervention report the characteristics of the population tested are similar to the clinical population where the intervention will be applied?</td>
</tr>
<tr>
<td rowspan="2">Intervention Effectiveness</td>
<td>1. How has the intervention been applied with this population?</td>
</tr>
<tr>
<td>2. Are the risk–benefit ratios of using the intervention known?</td>
</tr>
<tr>
<td rowspan="2">Comparative Treatment</td>
<td>1. What comparative treatments show evidence of better outcomes after treatment failure?</td>
</tr>
<tr>
<td>2. Which comparative treatment are demonstrated by the evidence have less risk to the patient?</td>
</tr>
<tr>
<td>Outcome</td>
<td>1. What is the level of satisfaction for patients and clinicians?</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The clinical application of the PICO model assumes that a clinician accurately identifies the clinical problem or diagnosis. On the surface, this may seem simplistic, but is complicated as many psychiatric syndromes are difficult to identify due to overlapping symptomatology not seen in research populations. EBP intervention studies are conducted using precisely defined populations and confirmed syndromes. Populations with comorbid conditions and unclear diagnoses, similar to clinical populations, are often excluded as part of the research process. The same ability to exclude comorbid conditions and select a precise diagnosis is frequently not an option in a clinical setting.</p>
<p>One of the most concerning examples is childhood attention deficit hyperactive disorder (ADHD) and childhood bipolar disorder (<xref ref-type="bibr" rid="bibr11-1078390313495563">Hegerl, Himmerich, Engmann, &amp; Hensch, 2010</xref>; <xref ref-type="bibr" rid="bibr18-1078390313495563">McIntyre, 2009</xref>; <xref ref-type="bibr" rid="bibr30-1078390313495563">Skirrow, Hosang, Farmer, &amp; Asherson, 2012</xref>). The clinical presentation of either syndrome can be difficult to separate because of overlapping symptoms. Hyperactivity, distractibility, and an inability to concentrate are in both ADHD and bipolar disorder. Studies on diagnostic accuracy report that almost all patients with ADHD receive the correct diagnosis, but the diagnosis of ADHD is misapplied to 38% of those with a major depressive disorder and 29% of those with a bipolar disorder (<xref ref-type="bibr" rid="bibr3-1078390313495563">Chilakamarri, Filkowski, &amp; Ghaemi, 2011</xref>). The need for the correct diagnosis is important when working with childhood bipolar disorder because ADHD stimulants may make the presenting symptoms worse (<xref ref-type="bibr" rid="bibr31-1078390313495563">Zeni, Tramontina, Ketzer, Pheula, &amp; Rohde, 2009</xref>).</p>
<p>The questions of the PICO application model also focus on the similarity of characteristics of the research study population to those of a given patient. There are a variety of characteristics on which the patient may not match those used to study the EBP intervention, including the severity of the illness, stage in treatment process, history of responsiveness/unresponsiveness to treatments, and patient values/preferences. If the patient’s presenting symptoms and background characteristics are too different from those in the study populations, then the intervention may not produce the same clinical outcomes.</p>
</sec>
<sec id="section3-1078390313495563">
<title>Intervention Effectiveness</title>
<p>Intervention effectiveness is measures by the strength, or statistical effect size, of a given condition (<xref ref-type="bibr" rid="bibr25-1078390313495563">Rice, 2009</xref>). Clinically, an intervention’s effect size is the amount of positive change in clinical condition. To determine if the intervention might be clinically effective for a specific patient, a clinician must ask two additional questions from PICO application model (<xref ref-type="table" rid="table1-1078390313495563">Table 1</xref>): (a) How has the intervention been applied with this population? (b) Are the risk–benefit ratios of using the intervention known for this population?</p>
<p>Correct application of EBP interventions require the intervention be used according to the guidelines established during the clinical trials. Treatment interventions that are not correctly applied at the same frequency, dose, or range are not supported by the evidence and will probably not produce the same clinical outcomes as reported in the literature. For example, there is little argument that the goal of treating depression is to obtain remission of the symptoms. Unfortunately, a significant portion of the population treated for depression does not achieve remission because EBP treatment guidelines are not followed. Current reports indicate only 56% of those receiving antidepressants completed an adequate course of treatment and only 63% received adequate treatment courses on a second antidepressant (<xref ref-type="bibr" rid="bibr23-1078390313495563">Murphy et al., 2012</xref>). While there is some variation in treatment response, the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trials at the National Institute of Mental Health indicate that a series of treatment steps, plus psychotherapy, produce the best outcomes (<xref ref-type="bibr" rid="bibr27-1078390313495563">Rush, 2007</xref>).</p>
</sec>
<sec id="section4-1078390313495563">
<title>Comparative Treatments</title>
<p>When faced with the dilemma of a patient suffering from a known problem, like major depression that has not responded to the first-line antidepressant, clinicians must consider the questions associated with using the comparative treatments (<xref ref-type="table" rid="table1-1078390313495563">Table1</xref>): (a) Is there evidence showing other treatment approaches have better treatment outcomes? (b) Which comparative treatments are demonstrated to have less risk to the patient?</p>
<p>The question of examining the best comparative treatment is again determined using the effect size of the tested interventions. In many cases, identification of the comparative option is easily identified as the second or third best treatment in a meta-analysis on treatment interventions. Again using a patient with unresponsive major depression, the STAR*D results indicate that for second-line interventions, about 25% became symptom-free using another selective serotonin reuptake inhibitor, and 33% of the remaining treatment failures became symptom-free when augmenting with buspirone (<xref ref-type="bibr" rid="bibr28-1078390313495563">Rush et al., 2008</xref>). The trials also indicated augmentation with cognitive behavioral therapy was enough to reduce depressive symptoms but require an average 14-week course of treatment (<xref ref-type="bibr" rid="bibr4-1078390313495563">Denninger et al., 2011</xref>; <xref ref-type="bibr" rid="bibr27-1078390313495563">Rush, 2007</xref>; <xref ref-type="bibr" rid="bibr28-1078390313495563">Rush et al., 2008</xref>).</p>
<p>A critical question that clinician’s must ask when looking at comparative treatments is the question of exposing the patient to a significant increase in risk, particularly when the evidence supporting the intervention is limited. An example of increasing risk in depression is use of second-generation antipsychotics (SGAs) for either monotherapy or augmentation of antidepressants (<xref ref-type="bibr" rid="bibr1-1078390313495563">Alexander, Gallagher, Mascola, Moloney, &amp; Stafford, 2011</xref>). In many cases there are no studies on using SGAs as a monotherapy, and some of the existing evidence indicates very little if any effect on depression (<xref ref-type="bibr" rid="bibr14-1078390313495563">Maglione et al., 2011</xref>; <xref ref-type="bibr" rid="bibr16-1078390313495563">Maher &amp; Theodore, 2012</xref>). Currently, only Aripirizol is approved by the U.S. Federal Drug Administration as an augmentation strategy, but not as a monotherapy, for treatment of resistant depression (<xref ref-type="bibr" rid="bibr14-1078390313495563">Maglione et al., 2011</xref>; <xref ref-type="bibr" rid="bibr15-1078390313495563">Maher et al., 2011</xref>). However, monotherapy or augmentation with other SGAs does increase the risk of exposing the patient to more serious long-term consequences, such as tardive dyskinesia, particularly for children and young adults (<xref ref-type="bibr" rid="bibr29-1078390313495563">Seida et al., 2012</xref>).</p>
</sec>
<sec id="section5-1078390313495563">
<title>Outcomes</title>
<p>One of the most difficult features of using EBP interventions is evaluating the outcomes. Clinical outcomes to EBP interventions are frequently defined simplistically as either obtaining the desired treatment response or the level of patient satisfaction. The reality is that EBP outcomes are more complicated and involve interaction between the treatments selected, the side effects, patient functionality, quality of life, and patient satisfaction (<xref ref-type="bibr" rid="bibr2-1078390313495563">Chang et al., 2006</xref>; <xref ref-type="bibr" rid="bibr13-1078390313495563">Kupfer &amp; Bond, 2012</xref>; <xref ref-type="bibr" rid="bibr22-1078390313495563">Miles &amp; Loughlin, 2011</xref>). EBP outcomes go beyond the defined treatment algorithm and clinicians must answer the question, “What is the level of satisfaction for both the patient and the clinician?”</p>
<p>The problems associated with identifying EBP outcomes are highlighted by the range of outcomes seen with antidepressant treatment (<xref ref-type="bibr" rid="bibr12-1078390313495563">Kennedy, Young, &amp; Blier, 2011</xref>). While clinician’s must be aware of the evidence indicating the superiority of one treatment approach, the individual patient’s side-effect response, functionality, desires, and satisfaction must be part of the formula (<xref ref-type="bibr" rid="bibr6-1078390313495563">Duncan &amp; Reese, 2013</xref>; <xref ref-type="bibr" rid="bibr10-1078390313495563">Hall, 2008</xref>; <xref ref-type="bibr" rid="bibr12-1078390313495563">Kennedy et al., 2011</xref>).</p>
<p>Answering the outcomes question in the clinical PICO model involves an open discussion with the patient about the treatment and alternatives. Discussion on evidence-based treatment recommendations must include full disclosure to the patient and a frank discussion of the risks and benefits of each treatment (<xref ref-type="bibr" rid="bibr20-1078390313495563">Melnyk &amp; Fineout-Overholt, 2005</xref>) including those with a smaller and less effective effect size. This discussion must also include the use of a treatment given the patient’s personal preferences and cultural beliefs and values of the patient (<xref ref-type="bibr" rid="bibr9-1078390313495563">Fineout-Overholt, Levin, &amp; Melnyk, 2004</xref>). This approach to examining EBP outcomes is increasingly referred to as patient centeredness and includes patient satisfaction that may not equate with EBP-defined intervention outcomes (<xref ref-type="bibr" rid="bibr13-1078390313495563">Kupfer &amp; Bond, 2012</xref>).</p>
</sec>
<sec id="section6-1078390313495563">
<title>Conclusion</title>
<p>The drive toward EBP is believed to generate cost savings due to more effective care with improved outcomes. Clinicians seeking to use EBP interventions are faced with a series of questions that are not well defined by the scientific process. Clinicians can use the clinical PICO model to answer a series of clinically oriented questions. These questions focus the EBP intervention and enhance the possibility of achieving a good clinical outcome. Central to that outcome must be determining both the clinician’s and patient’s satisfaction in several areas. This determination can only be reached by engaging the patient in the oldest of health care traditions, establishing a therapeutic contract.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alexander</surname><given-names>G. C.</given-names></name>
<name><surname>Gallagher</surname><given-names>S. A.</given-names></name>
<name><surname>Mascola</surname><given-names>A.</given-names></name>
<name><surname>Moloney</surname><given-names>R. M.</given-names></name>
<name><surname>Stafford</surname><given-names>R. S.</given-names></name>
</person-group> (<year>2011</year>). <article-title>Increasing off-label use of antipsychotic medications in the United States, 1995-2008</article-title>. <source>Pharmacoepidemiology and Drug Safety</source>, <volume>20</volume>, <fpage>177</fpage>-<lpage>184</lpage>. doi:<pub-id pub-id-type="doi">10.1002/pds.2082</pub-id></citation>
</ref>
<ref id="bibr2-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chang</surname><given-names>J. T.</given-names></name>
<name><surname>Hays</surname><given-names>R. D.</given-names></name>
<name><surname>Shekelle</surname><given-names>P. G.</given-names></name>
<name><surname>MacLean</surname><given-names>C. H.</given-names></name>
<name><surname>Solomon</surname><given-names>D. H.</given-names></name>
<name><surname>Reuben</surname><given-names>D. B.</given-names></name>
<name><surname>Wenger</surname><given-names>N. S.</given-names></name>
</person-group> (<year>2006</year>). <article-title>Patients’ global ratings of their health care are not associated with the technical quality of their care</article-title>. <source>Annals of Internal Medicine</source>, <volume>144</volume>, <fpage>665</fpage>-<lpage>672</lpage>.</citation>
</ref>
<ref id="bibr3-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chilakamarri</surname><given-names>J. K.</given-names></name>
<name><surname>Filkowski</surname><given-names>M. M.</given-names></name>
<name><surname>Ghaemi</surname><given-names>S. N.</given-names></name>
</person-group> (<year>2011</year>). <article-title>Misdiagnosis of bipolar disorder in children and adolescents: A comparison with ADHD and major depressive disorder</article-title>. <source>Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists</source>, <volume>23</volume>(<issue>1</issue>), <fpage>25</fpage>-<lpage>29</lpage>.</citation>
</ref>
<ref id="bibr4-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Denninger</surname><given-names>J. W.</given-names></name>
<name><surname>van Nieuwenhuizen</surname><given-names>A. O.</given-names></name>
<name><surname>Wisniewski</surname><given-names>S. R.</given-names></name>
<name><surname>Luther</surname><given-names>J. F.</given-names></name>
<name><surname>Trivedi</surname><given-names>M. H.</given-names></name>
<name><surname>Rush</surname><given-names>A. J.</given-names></name>
<name><surname>Fava</surname><given-names>M.</given-names></name>
</person-group> (<year>2011</year>). <article-title>Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study</article-title>. <source>Journal of Nervous and Mental Disease</source>, <volume>199</volume>, <fpage>807</fpage>-<lpage>810</lpage>. doi:<pub-id pub-id-type="doi">10.1097/NMD.0b013e31822fcbe2</pub-id></citation>
</ref>
<ref id="bibr5-1078390313495563">
<citation citation-type="gov"><collab>Department of Health and Human Services</collab>. (<year>2011</year>). <source>National strategy for quality improvement in health care</source>. Retrieved from <ext-link ext-link-type="uri" xlink:href="http://www.ahrq.gov/workingforquality/nqs/nqs2012annlrpt.pdf">http://www.ahrq.gov/workingforquality/nqs/nqs2012annlrpt.pdf</ext-link></citation>
</ref>
<ref id="bibr6-1078390313495563">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Duncan</surname><given-names>B. L.</given-names></name>
<name><surname>Reese</surname><given-names>R. J.</given-names></name>
</person-group> (<year>2013</year>). <article-title>Empirically supported treatments, evidence-based treatments, and evidence-based practice</article-title>. In <person-group person-group-type="editor">
<name><surname>Stricker</surname><given-names>G.</given-names></name>
<name><surname>Widiger</surname><given-names>T. A.</given-names></name>
<name><surname>Weiner</surname><given-names>I. B.</given-names></name>
</person-group> (Eds.), <source>Handbook of psychology</source> (pp. <fpage>489</fpage>-<lpage>513</lpage>). <publisher-loc>Hoboken, NJ</publisher-loc>: <publisher-name>John Wiley</publisher-name>.</citation>
</ref>
<ref id="bibr7-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fineout-Overholt</surname><given-names>E.</given-names></name>
<name><surname>Johnston</surname><given-names>L.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Teaching EBP: Asking searchable, answerable clinical questions</article-title>. <source>Worldviews on Evidence-Based Nursing</source>, <volume>2</volume>, <fpage>157</fpage>-<lpage>160</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1741-6787.2005.00032.x</pub-id></citation>
</ref>
<ref id="bibr8-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fineout-Overholt</surname><given-names>E.</given-names></name>
<name><surname>Johnston</surname><given-names>L.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Evaluation: An essential step to the EBP process</article-title>. <source>Worldviews on Evidence-Based Nursing</source>, <volume>4</volume>, <fpage>54</fpage>-<lpage>59</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1741-6787.2007.00081.x</pub-id></citation>
</ref>
<ref id="bibr9-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fineout-Overholt</surname><given-names>E.</given-names></name>
<name><surname>Levin</surname><given-names>R. F.</given-names></name>
<name><surname>Melnyk</surname><given-names>B. M.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Strategies for advancing evidence-based practice in clinical settings</article-title>. <source>Journal of the New York State Nurses Association</source>, <volume>35</volume>(<issue>2</issue>), <fpage>28</fpage>-<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr10-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hall</surname><given-names>M. F.</given-names></name>
</person-group> (<year>2008</year>). <article-title>Looking to improve financial results? Start by listening to patients</article-title>. <source>Healthcare Financial Management</source>, <volume>62</volume>(<issue>10</issue>), <fpage>76</fpage>-<lpage>80</lpage>.</citation>
</ref>
<ref id="bibr11-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hegerl</surname><given-names>U.</given-names></name>
<name><surname>Himmerich</surname><given-names>H.</given-names></name>
<name><surname>Engmann</surname><given-names>B.</given-names></name>
<name><surname>Hensch</surname><given-names>T.</given-names></name>
</person-group> (<year>2010</year>). <article-title>Mania and attention-deficit/hyperactivity disorder: Common symptomatology, common pathophysiology and common treatment?</article-title> <source>Current Opinion in Psychiatry</source>, <volume>23</volume>(<issue>1</issue>), <fpage>1</fpage>-<lpage>7</lpage>. doi:<pub-id pub-id-type="doi">10.1097/YCO.0b013e328331f694</pub-id></citation>
</ref>
<ref id="bibr12-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kennedy</surname><given-names>S. H.</given-names></name>
<name><surname>Young</surname><given-names>A. H.</given-names></name>
<name><surname>Blier</surname><given-names>P.</given-names></name>
</person-group> (<year>2011</year>). <article-title>Strategies to achieve clinical effectiveness: Refining existing therapies and pursuing emerging targets</article-title>. <source>Journal of Affective Disorders</source>, <volume>132</volume>, <fpage>S21</fpage>-<lpage>S28</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2011.03.048</pub-id></citation>
</ref>
<ref id="bibr13-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kupfer</surname><given-names>J. M.</given-names></name>
<name><surname>Bond</surname><given-names>E. U.</given-names></name>
</person-group> (<year>2012</year>). <article-title>Patient satisfaction and patient-centered care: Necessary but not equal</article-title>. <source>JAMA: Journal of the American Medical Association</source>, <volume>308</volume>, <fpage>139</fpage>-<lpage>140</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2012.7381</pub-id></citation>
</ref>
<ref id="bibr14-1078390313495563">
<citation citation-type="gov">
<person-group person-group-type="author">
<name><surname>Maglione</surname><given-names>M.</given-names></name>
<name><surname>Maher</surname><given-names>A.</given-names></name>
<name><surname>Hu</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Shanman</surname><given-names>R.</given-names></name>
<name><surname>Shekelle</surname><given-names>P.</given-names></name>
<name><surname>Perry</surname><given-names>T.</given-names></name>
</person-group> (<year>2011</year>). <source>Off-label use of atypical antipsychotics: An update</source>. <publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>Agency for Healthcare Research and Quality</publisher-name> (Comparative Effectiveness Reviews, No. 43). Retrieved from <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK66081/">http://www.ncbi.nlm.nih.gov/books/NBK66081/</ext-link></citation>
</ref>
<ref id="bibr15-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maher</surname><given-names>A. R.</given-names></name>
<name><surname>Maglione</surname><given-names>M.</given-names></name>
<name><surname>Bagley</surname><given-names>S.</given-names></name>
<name><surname>Suttorp</surname><given-names>M.</given-names></name>
<name><surname>Hu</surname><given-names>J. H.</given-names></name>
<name><surname>Ewing</surname><given-names>B.</given-names></name>
<name><surname>Shekelle</surname><given-names>P. G.</given-names></name>
</person-group> (<year>2011</year>). <article-title>Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: A systematic review and meta-analysis</article-title>. <source>JAMA: Journal of the American Medical Association</source>, <volume>306</volume>, <fpage>1359</fpage>-<lpage>1369</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2011.1360</pub-id></citation>
</ref>
<ref id="bibr16-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maher</surname><given-names>A. R.</given-names></name>
<name><surname>Theodore</surname><given-names>G.</given-names></name>
</person-group> (<year>2012</year>). <article-title>Summary of the comparative effectiveness review on off-label use of atypical antipsychotics</article-title>. <source>Journal of Managed Care Pharmacy</source>, <volume>18</volume>(<issue>5</issue> <supplement>Suppl. B</supplement>), <fpage>1</fpage>-<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr17-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McAlister</surname><given-names>F. A.</given-names></name>
<name><surname>Straus</surname><given-names>S. E.</given-names></name>
<name><surname>Guyatt</surname><given-names>G. H.</given-names></name>
<name><surname>Haynes</surname><given-names>R. B.</given-names></name>
</person-group> (<year>2000</year>). <article-title>Users’ guides to the medical literature: XX. Integrating research evidence with the care of the individual patient. evidence-based medicine working group</article-title>. <source>JAMA: Journal of the American Medical Association</source>, <volume>283</volume>, <fpage>2829</fpage>-<lpage>2836</lpage>.</citation>
</ref>
<ref id="bibr18-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McIntyre</surname><given-names>R.</given-names></name>
</person-group> (<year>2009</year>). <article-title>Bipolar disorder and ADHD: Clinical concerns</article-title>. <source>CNS Spectrums</source>, <volume>14</volume>(<issue>7</issue> <supplement>Suppl. 6</supplement>), <fpage>8</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr19-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Melnyk</surname><given-names>B. M.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Finding and appraising systematic reviews of clinical interventions: Critical skills for evidence-based practice</article-title>. <source>Pediatric Nursing</source>, <volume>29</volume>, <fpage>147</fpage>-<lpage>149</lpage>.</citation>
</ref>
<ref id="bibr20-1078390313495563">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Melnyk</surname><given-names>B. M.</given-names></name>
<name><surname>Fineout-Overholt</surname><given-names>E.</given-names></name>
</person-group> (<year>2005</year>). <source>Evidence based practice in nursing and health care: A guide to best practice</source>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Lippincott, Williams &amp; Wilkins</publisher-name>.</citation>
</ref>
<ref id="bibr21-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Melnyk</surname><given-names>B. M.</given-names></name>
<name><surname>Fineout-Overholt</surname><given-names>E.</given-names></name>
</person-group> (<year>2006</year>). <article-title>Consumer preferences and values as an integral key to evidence-based practice</article-title>. <source>Nursing Administration Quarterly</source>, <volume>30</volume>, <fpage>123</fpage>-<lpage>127</lpage>.</citation>
</ref>
<ref id="bibr22-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Miles</surname><given-names>A.</given-names></name>
<name><surname>Loughlin</surname><given-names>M.</given-names></name>
</person-group> (<year>2011</year>). <article-title>Models in the balance: Evidence-based medicine versus evidence-informed individualized care</article-title>. <source>Journal of Evaluation in Clinical Practice</source>, <volume>17</volume>, <fpage>531</fpage>-<lpage>536</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2753.2011.01713.x</pub-id></citation>
</ref>
<ref id="bibr23-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>M.</given-names></name>
<name><surname>Brown</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Sabin</surname><given-names>J.</given-names></name>
<name><surname>Yin</surname><given-names>R.</given-names></name>
<name><surname>Toh</surname><given-names>D.</given-names></name>
</person-group> (<year>2012</year>). <article-title>PS2-20: Identifying treatment resistant depression in administrative claims databases</article-title>. <source>Clinical Medicine &amp; Research</source>, <volume>10</volume>(<issue>3</issue>), <fpage>181</fpage>. doi:<pub-id pub-id-type="doi">10.3121/cmr.2012.1100.ps2-20</pub-id></citation>
</ref>
<ref id="bibr24-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rice</surname><given-names>M. J.</given-names></name>
</person-group> (<year>2008</year>). <article-title>Psychiatric mental health evidence-based practice</article-title>. <source>Journal of the American Psychiatric Nurses Association</source>, <volume>14</volume>, <fpage>107</fpage>-<lpage>111</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1078390308315798</pub-id></citation>
</ref>
<ref id="bibr25-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rice</surname><given-names>M. J.</given-names></name>
</person-group> (<year>2009</year>). <article-title>Effect size in psychiatric evidence-based practice care</article-title>. <source>Journal of the American Psychiatric Nurses Association</source>, <volume>15</volume>, <fpage>138</fpage>-<lpage>142</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1078390309335007</pub-id></citation>
</ref>
<ref id="bibr26-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rice</surname><given-names>M. J.</given-names></name>
</person-group> (<year>2010</year>). <article-title>Evidence-based practice problems: Form and focus</article-title>. <source>Journal of the American Psychiatric Nurses Association</source>, <volume>16</volume>, <fpage>307</fpage>-<lpage>314</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1078390310374990</pub-id></citation>
</ref>
<ref id="bibr27-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rush</surname><given-names>A. J.</given-names></name>
</person-group> (<year>2007</year>). <article-title>STAR*D: What have we learned?</article-title> <source>American Journal of Psychiatry</source>, <volume>164</volume>, <fpage>201</fpage>-<lpage>204</lpage>. doi:<pub-id pub-id-type="doi">10.1176/appi.ajp.164.2.201</pub-id></citation>
</ref>
<ref id="bibr28-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rush</surname><given-names>A. J.</given-names></name>
<name><surname>Wisniewski</surname><given-names>S. R.</given-names></name>
<name><surname>Warden</surname><given-names>D.</given-names></name>
<name><surname>Luther</surname><given-names>J. F.</given-names></name>
<name><surname>Davis</surname><given-names>L. L.</given-names></name>
<name><surname>Fava</surname><given-names>M.</given-names></name>
<name><surname>Trivedi</surname><given-names>M. H.</given-names></name>
</person-group> (<year>2008</year>). <article-title>Selecting among second-step antidepressant medication monotherapies: Predictive value of clinical, demographic, or first-step treatment features</article-title>. <source>Archives of General Psychiatry</source>, <volume>65</volume>, <fpage>870</fpage>-<lpage>880</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archpsyc.65.8.870</pub-id></citation>
</ref>
<ref id="bibr29-1078390313495563">
<citation citation-type="gov">
<person-group person-group-type="author">
<name><surname>Seida</surname><given-names>J.</given-names></name>
<name><surname>Schouten</surname><given-names>J.</given-names></name>
<name><surname>Mousavi</surname><given-names>S.</given-names></name>
<name><surname>Hamm</surname><given-names>M.</given-names></name>
<name><surname>Beaith</surname><given-names>A.</given-names></name>
<name><surname>Vandermeer</surname><given-names>B.</given-names></name>
<name><surname>Carrey</surname><given-names>N.</given-names></name>
</person-group> (<year>2012</year>). <source>First- and second-generation antipsychotics for children and young adults. Comparative effectiveness review</source>. Retrieved from <ext-link ext-link-type="uri" xlink:href="http://www.effectivehealthcare.ahrq.gov/ehc/products/147/918/CER39_First-and-Second-Generation-Antipsychotics_execsumm_20120104.pdf">http://www.effectivehealthcare.ahrq.gov/ehc/products/147/918/CER39_First-and-Second-Generation-Antipsychotics_execsumm_20120104.pdf</ext-link></citation>
</ref>
<ref id="bibr30-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Skirrow</surname><given-names>C.</given-names></name>
<name><surname>Hosang</surname><given-names>G. M.</given-names></name>
<name><surname>Farmer</surname><given-names>A. E.</given-names></name>
<name><surname>Asherson</surname><given-names>P.</given-names></name>
</person-group> (<year>2012</year>). <article-title>An update on the debated association between ADHD and bipolar disorder across the lifespan</article-title>. <source>Journal of Affective Disorders</source>, <volume>141</volume>, <fpage>143</fpage>-<lpage>159</lpage>. doi:<pub-id pub-id-type="doi">10.1016/ j.jad.2012.04.003</pub-id></citation>
</ref>
<ref id="bibr31-1078390313495563">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zeni</surname><given-names>C. P.</given-names></name>
<name><surname>Tramontina</surname><given-names>S.</given-names></name>
<name><surname>Ketzer</surname><given-names>C. R.</given-names></name>
<name><surname>Pheula</surname><given-names>G. F.</given-names></name>
<name><surname>Rohde</surname><given-names>L. A.</given-names></name>
</person-group> (<year>2009</year>). <article-title>Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: A randomized crossover trial</article-title>. <source>Journal of Child and Adolescent Psychopharmacology</source>, <volume>19</volume>, <fpage>553</fpage>-<lpage>561</lpage>. doi:<pub-id pub-id-type="doi">10.1089/cap.2009.0037</pub-id></citation>
</ref>
</ref-list>
</back>
</article>